Publication dates

All regions

Rheumatoid Arthritis Industry, August 2014 Market Reports from Top Publishers

You might be interested in: disease testing, therapeutics, medical equipment, more »


 
1-20 of about 8 900 reports for Rheumatoid Arthritis

Global Rheumatoid Arthritis Drugs Market 2014-2018

Global Rheumatoid Arthritis Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

... Global rheumatoid arthritis drugs market 2014-2018 about rheumatoid arthritisra is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees ...

 Juvenile Rheumatoid Arthritis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Juvenile Rheumatoid Arthritis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of juvenile rheumatoid arthritis key products to exploit opportunities for generic drug development opportunities. - Identify ...

 Systemic Juvenile Rheumatoid Arthritis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Systemic Juvenile Rheumatoid Arthritis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... And exclusivity details of systemic juvenile rheumatoid arthritis key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types ...

Amgen, Inc. - Strategy and SWOT Report

Amgen, Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • June 2014
  • by MarketLine

... Engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious ...

CrystalGenomics, Inc. - Product Pipeline Review - 2014

CrystalGenomics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

... Small molecule to inhibit bruton agammaglobulinemia tyrosine kinase for cancer and rheumatoid arthritis 22product description 22mechanism of action 22r&d progress 22small molecule to inhibit ...

Entia Biosciences, Inc. (ERGO) - Financial and Strategic SWOT Analysis Review

Entia Biosciences, Inc. (ERGO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Hemo, ergo-d2-flex-ra, and ergo-d2-hsn. The company's ergo-d2-hemo is a medical nutrition solution used for treatment of diabetes and anemia; ergo-d2-flex-ra is solution used to treat rheumatoid ...

Medical & Biological Laboratories Co., Ltd. (4557) - Financial and Strategic SWOT Analysis Review

Medical & Biological Laboratories Co., Ltd. (4557) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Of allergy, antiphospholipid syndrome, autoimmune skin diseases, connective tissue diseases, hepatitis, liver diseases, rheumatoid arthritis, tumor marker, vasculitis and infectious diseases. It has its ...

4SC AG (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

4SC AG (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

... For the treatment of inflammatory bowel disease and rheumatoid arthritis. The company is also conducting research programs related to cancer stem cells, ion channel blockers and cycotine modulation.4Sc ag key ...

Almirall, S.A. (Symbol:ALM) SWOT Analysis, Strategy, Revenues and Profits

Almirall, S.A. (Symbol:ALM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

... Such as actikerall, almax, balneum. The company's products focus on treating respiratory diseases, including asthma and copd; autoimmune diseases including rheumatoid arthritis and multiple sclerosis; dermatological ...

 Rheumatoid Arthritis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Rheumatoid Arthritis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... And exclusivity details of rheumatoid arthritis key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under ...

About 1 600 reports for Rheumatoid Arthritis

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Pricing Pfizer's Tofacitinib to Treatrheumatoid Arthritis:opport...
  • September 2012
    34 pages
  • Rheumatoid Arth...  

    Drug  

  • United States  

View report >

1 Companies for Rheumatoid Arthritis

Read our Company Profiles

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.